Monitor the pace of housing starts recovery and raw material cost normalization for core gas piping business. Track MediTrac CMT commercial traction in European markets as a potential growth catalyst that could offset core weakness.
Price Chart
Executive Summary
Omega Flex reported Q2 2026 net sales of $24.1M (down 5.8% YoY) and EPS of $0.27 (down 34.1% YoY), driven by lower housing starts, higher raw material costs, and tariffs. The company also announced CE Mark approval for its MediTrac corrugated medical tubing, a potential new growth platform. The combination of declining core financials and a promising but early-stage regulatory milestone produces a mixed outlook.
Key Financial Metrics
Key Facts
- Q2 2026 net sales $24.1M, down 5.8% YoY from $25.5M
- Q2 2026 EPS $0.27, down 34.1% YoY from $0.41
- Net income for Q2 2026 was $2.7M, down 35.6% YoY from $4.2M
- Decline driven by lower housing starts, higher raw material costs, tariffs, and marketing/product certification expenses
- MediTrac CMT received CE Mark certification under EU MDR 2017/745 as a Class IIa medical device
- New re-engineered TracPipe fitting introduced July 1, 2026, targeting residential and commercial markets
Financial Impact
Q2 net sales down $1.5M (-5.8% YoY); net income down $1.5M (-35.6% YoY); EPS down $0.14 (-34.1% YoY)
Risk Factors
- Continued decline in housing starts suppressing sales volumes
- Persistent raw material cost inflation and tariff headwinds
- MediTrac CMT revenue ramp may take longer than expected
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3344090 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 18, 2026 5w ago | Press Release | $25.41 | awaiting T+60 | — | $24.29 (−4.40%) |
Aug 12, 2026 10w ago | Press Release | $28.81 | awaiting T+60 | — | $24.29 (−15.69%) |
Aug 12, 2026 10w ago | 8-K | $28.81 | awaiting T+60 | — | $24.29 (−15.69%) |
Jun 15, 2026 19w ago | 8-K | $30.96 | awaiting T+60 | — | $24.29 (−21.54%) |
Apr 28, 2026 25w ago | DEFA14A | $34.21 $29.45 | ▼ −13.91% | ▼ −17.90% | $24.29 (−29.00%) |
Mar 25, 2026 30w ago | Press Release | $29.74 $30.32 | ▲ +1.93% | ▼ −12.02% | $24.29 (−18.34%) |
Mar 4, 2026 33w ago | 8-K | $30.40 $29.90 | ▲ +1.64% | ▲ +12.94% | $24.29 (+20.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers